dipyridamole has been researched along with Hemolysis in 19 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Hemolysis: The destruction of ERYTHROCYTES by many different causal agents such as antibodies, bacteria, chemicals, temperature, and changes in tonicity.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hemolysis is a frequent adverse effect of ribavirin (RBV)." | 9.11 | Low membrane protein sulfhydrils but not G6PD deficiency predict ribavirin-induced hemolysis in hepatitis C. ( Bihl, F; Grattagliano, I; Jüni, P; Lauterburg, BH; Palasciano, G; Palmieri, VO; Portincasa, P; Russmann, S, 2004) |
| "Hemolysis is a frequent adverse effect of ribavirin (RBV)." | 5.11 | Low membrane protein sulfhydrils but not G6PD deficiency predict ribavirin-induced hemolysis in hepatitis C. ( Bihl, F; Grattagliano, I; Jüni, P; Lauterburg, BH; Palasciano, G; Palmieri, VO; Portincasa, P; Russmann, S, 2004) |
| "Today, treatment of chronic hepatitis C is based on a synergistic combination of pegylated interferon and ribavirin with antiprotease inhibitors." | 3.78 | A new tool to study ribavirin-induced haemolysis. ( Brochot, E; Capron, D; Castelain, S; Duchaussoy, I; Duverlie, G; François, C; Helle, F; Nguyen-Khac, E; Van Nhien, AN, 2012) |
| "WBC-reduced RBC suspensions (30% Hct) were treated with 1,9-dimethylmethylene blue and red light, and the influence of the inclusion of DIP on photohemolysis was assessed as a function of sensitizer concentration, light dose, and storage time." | 3.71 | The band III ligand dipyridamole protects human RBCs during photodynamic treatment while extracellular virus inactivation is not affected. ( Besselink, GA; Blokker, DE; Brand, A; De Korte, D; Korsten, HG; Lagerberg, JW; Van Engelenburg, FA; Verhoeven, AJ, 2002) |
| "Dipyridamole was also inactive in vitro, unless red blood cell injury was deliberately enhanced, thereby increasing the level of free adenine nucleotides." | 2.67 | Dipyridamole potentiates platelet inhibition by nitric oxide. ( Bult, H; Fret, HR; Herman, AG; Jordaens, FH, 1991) |
| "Erythrocytes from patients with Huntington's disease showed no significant differences from erythrocytes of normal adults." | 1.26 | Lysophosphatidylcholine-induced lysis of erythrocytes in Duchenne and myotonic dystrophies and in Huntington's disease. ( Barr, AN; Danon, MJ; Lazowski, E; Omachi, A; Podolski, JL; Sarpel, G, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (63.16) | 18.7374 |
| 1990's | 1 (5.26) | 18.2507 |
| 2000's | 4 (21.05) | 29.6817 |
| 2010's | 1 (5.26) | 24.3611 |
| 2020's | 1 (5.26) | 2.80 |
| Authors | Studies |
|---|---|
| Zhelankin, AV | 1 |
| Iulmetova, LN | 1 |
| Sharova, EI | 1 |
| Brochot, E | 1 |
| François, C | 1 |
| Castelain, S | 1 |
| Helle, F | 1 |
| Van Nhien, AN | 1 |
| Duchaussoy, I | 1 |
| Capron, D | 1 |
| Nguyen-Khac, E | 1 |
| Duverlie, G | 1 |
| Besselink, GA | 2 |
| Van Engelenburg, FA | 2 |
| Korsten, HG | 1 |
| Blokker, DE | 1 |
| Lagerberg, JW | 1 |
| Brand, A | 1 |
| De Korte, D | 2 |
| Verhoeven, AJ | 2 |
| Ebbing, IG | 1 |
| Hilarius, PM | 1 |
| DEUTICKE, B | 1 |
| DUHM, J | 1 |
| GERLACH, E | 1 |
| Grattagliano, I | 1 |
| Russmann, S | 1 |
| Palmieri, VO | 1 |
| Jüni, P | 1 |
| Bihl, F | 1 |
| Portincasa, P | 1 |
| Palasciano, G | 1 |
| Lauterburg, BH | 1 |
| Omachi, A | 1 |
| Sarpel, G | 1 |
| Podolski, JL | 1 |
| Barr, AN | 1 |
| Lazowski, E | 1 |
| Danon, MJ | 1 |
| Häussinger, G | 1 |
| Pfennigs, H | 1 |
| Chelapurath, A | 1 |
| Reul, H | 1 |
| Essers, U | 1 |
| Ruggiero, AC | 1 |
| Nepomuceno, MF | 1 |
| Jacob, RF | 1 |
| Dorta, DJ | 1 |
| Tabak, M | 1 |
| Dale, J | 1 |
| Myhre, E | 1 |
| Rootwelt, K | 1 |
| Dollinger, MR | 1 |
| Krakoff, IH | 1 |
| Bult, H | 1 |
| Fret, HR | 1 |
| Jordaens, FH | 1 |
| Herman, AG | 1 |
| Gewirtz, H | 1 |
| Brown, P | 1 |
| Most, AS | 1 |
| Ferber, E | 1 |
| Munder, PG | 1 |
| Kohlschütter, A | 1 |
| Fischer, H | 1 |
| Nishino, T | 1 |
| Manohitharajah, SM | 1 |
| Rahman, AN | 1 |
| Donnelly, RJ | 1 |
| Deverall, PB | 1 |
| Watson, DA | 1 |
| Di Perri, T | 1 |
| Auteri, A | 1 |
| Volpi, L | 1 |
| Odake, K | 1 |
| Ambrus, JL | 1 |
| Bishop, C | 1 |
| Philipp, G | 1 |
| Ruckpaul, K | 1 |
| Banaschak, H | 1 |
| Jung, F | 1 |
2 trials available for dipyridamole and Hemolysis
| Article | Year |
|---|---|
Low membrane protein sulfhydrils but not G6PD deficiency predict ribavirin-induced hemolysis in hepatitis C.
Topics: Adult; Antiviral Agents; Cell Membrane; Dipyridamole; Erythrocytes; Female; Glutathione; Glutathione | 2004 |
Dipyridamole potentiates platelet inhibition by nitric oxide.
Topics: Adult; Dipyridamole; Double-Blind Method; Drug Synergism; Endothelium, Vascular; Female; Hemolysis; | 1991 |
17 other studies available for dipyridamole and Hemolysis
| Article | Year |
|---|---|
The Impact of the Anticoagulant Type in Blood Collection Tubes on Circulating Extracellular Plasma MicroRNA Profiles Revealed by Small RNA Sequencing.
Topics: Adenosine; Adult; Anticoagulants; Blood Specimen Collection; Circulating MicroRNA; Citrates; Dipyrid | 2022 |
A new tool to study ribavirin-induced haemolysis.
Topics: Adenosine Triphosphate; Adult; Anemia, Hemolytic; Dipyridamole; Drug Evaluation, Preclinical; Drug T | 2012 |
The band III ligand dipyridamole protects human RBCs during photodynamic treatment while extracellular virus inactivation is not affected.
Topics: Anion Exchange Protein 1, Erythrocyte; Diarrhea Viruses, Bovine Viral; Dipyridamole; Encephalomyocar | 2002 |
Additive effects of dipyridamole and Trolox in protecting human red cells during photodynamic treatment.
Topics: Antioxidants; Cell Membrane Permeability; Chromans; Dipyridamole; Drug Combinations; Drug Synergism; | 2003 |
[ALTERATION OF THE MONOSACCHARIDE PERMEABILITY OF HUMAN ERYTHROCYTES BY A PYRIMIDO-PYRIMIDINE COMPOUND].
Topics: Carbohydrate Metabolism; Cell Membrane Permeability; Dipyridamole; Erythrocytes; Hematocrit; Hemolys | 1964 |
Lysophosphatidylcholine-induced lysis of erythrocytes in Duchenne and myotonic dystrophies and in Huntington's disease.
Topics: Adult; Child; Dipyridamole; Dose-Response Relationship, Drug; Erythrocytes; Hemolysis; Humans; Hunti | 1982 |
[Influence of platelet aggregation inhibitors on platelet damage at prosthetic heart valves in-vitro (author's transl)].
Topics: Aspirin; Blood Platelets; Dipyridamole; Heart Valve Prosthesis; Hemolysis; Humans; Lysine; Platelet | 1981 |
Antioxidant effect of dipyridamole (DIP) and its derivative RA 25 upon lipid peroxidation and hemolysis in red blood cells.
Topics: Animals; Antioxidants; Cells, Cultured; Dipyridamole; Dose-Response Relationship, Drug; Erythrocyte | 2000 |
Effects of dipyridamole and acetylsalicylic acid on platelet functions in patients with aortic ball-valve prostheses.
Topics: Aortic Valve; Aspirin; Blood Platelets; Cell Survival; Dipyridamole; Half-Life; Heart Valve Prosthes | 1975 |
Hemolysis induced by 6-N-hydroxylaminopurine riboside, an adenosine analogue.
Topics: Adenosine; Adult; Bilirubin; Blood Cell Count; Breast Neoplasms; Dipyridamole; Erythrocytes; Female; | 1975 |
Measurement of plasma adenosine concentration: methodological and physiological considerations.
Topics: Adenine; Adenosine; Dipyridamole; Erythrocytes; False Positive Reactions; Hemolysis; Humans; Indicat | 1987 |
[Studies on the lysolecithin-metabolizing enzymes of intact erythrocytes and modified stromas].
Topics: Acyltransferases; Adenosine Triphosphate; Amitriptyline; Antibodies; Cell Membrane; Chlorpromazine; | 1968 |
[Studies on platelet adhesiveness. I. The effects of various drugs in vitro].
Topics: Adenosine; Adenosine Diphosphate; Dipyridamole; Fibrinolysin; Fibrinolytic Agents; Glucose; Hematocr | 1970 |
Platelet survival in patients with homograft and prosthetic heart valves. Correlation with incidence of thromboembolism.
Topics: Anticoagulants; Blood Cell Count; Blood Platelet Disorders; Blood Platelets; Cell Survival; Chromium | 1974 |
[Anti-complement action of dipyridamole. Localization of the point of attack of the drug].
Topics: Complement System Proteins; Dipyridamole; Hemolysis; Humans | 1971 |
Assay for erythrocyte adenosine monophosphate deaminase (AMP aminohydrolase, EC 3.5.4.6) and effects of certain blood preservatives on this enzyme.
Topics: Adenine; Adenine Nucleotides; Aminohydrolases; Blood Preservation; Chromatography, Ion Exchange; Dep | 1969 |
[Effect of dipyridamole on blood preservation].
Topics: Adenosine Triphosphate; Blood Preservation; Dipyridamole; Erythrocytes; Glyceric Acids; Hemolysis; H | 1969 |